ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Medicine for the Treatment of Advanced Thyroid Cancer Market Research Report 2025
Published Date: July 2025
|
Report Code: QYRE-Auto-7E13755
Home | Market Reports | Health| Health Conditions| Cancer
Global Medicine for the Treatment of Advanced Thyroid Cancer Market Research Report 2023
BUY CHAPTERS

Global Medicine for the Treatment of Advanced Thyroid Cancer Market Research Report 2025

Code: QYRE-Auto-7E13755
Report
July 2025
Pages:78
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Bayer
Astrazeneca plc
Sanofi
Exelixis Inc
Ipsen Pharma
Eisai Co Ltd

Medicine for the Treatment of Advanced Thyroid Cancer Market Size

The global market for Medicine for the Treatment of Advanced Thyroid Cancer was valued at US$ 488 million in the year 2024 and is projected to reach a revised size of US$ 744 million by 2031, growing at a CAGR of 6.3% during the forecast period.

Medicine for the Treatment of Advanced Thyroid Cancer Market

Medicine for the Treatment of Advanced Thyroid Cancer Market

Thyroid cancer is the most common endocrine tumor. Four targeted agents (vandetanib, cabozantinib, sorafenib, and lenvatinib) have attained regulatory approval for advanced thyroid cancer, and several other related agents are now commonly used off-label as first- and second-line treatments for selected patients.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Medicine for the Treatment of Advanced Thyroid Cancer, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Medicine for the Treatment of Advanced Thyroid Cancer.
The Medicine for the Treatment of Advanced Thyroid Cancer market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Medicine for the Treatment of Advanced Thyroid Cancer market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Medicine for the Treatment of Advanced Thyroid Cancer manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Medicine for the Treatment of Advanced Thyroid Cancer Market Report

Report Metric Details
Report Name Medicine for the Treatment of Advanced Thyroid Cancer Market
Accounted market size in year US$ 488 million
Forecasted market size in 2031 US$ 744 million
CAGR 6.3%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • Cabozantinib
  • Sorafenib
  • Vandetanib
  • Lenvatinib
Segment by Application
  • Combination therapy
  • Solo Medication
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Bayer, AstraZeneca, Sanofi, Exelixis Inc., Ipsen Pharma, Eisai Inc
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Medicine for the Treatment of Advanced Thyroid Cancer manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Medicine for the Treatment of Advanced Thyroid Cancer in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Medicine for the Treatment of Advanced Thyroid Cancer Market growing?

Ans: The Medicine for the Treatment of Advanced Thyroid Cancer Market witnessing a CAGR of 6.3% during the forecast period 2025-2031.

What is the Medicine for the Treatment of Advanced Thyroid Cancer Market size in 2031?

Ans: The Medicine for the Treatment of Advanced Thyroid Cancer Market size in 2031 will be US$ 744 million.

Who are the main players in the Medicine for the Treatment of Advanced Thyroid Cancer Market report?

Ans: The main players in the Medicine for the Treatment of Advanced Thyroid Cancer Market are Bayer, AstraZeneca, Sanofi, Exelixis Inc., Ipsen Pharma, Eisai Inc

What are the Application segmentation covered in the Medicine for the Treatment of Advanced Thyroid Cancer Market report?

Ans: The Applications covered in the Medicine for the Treatment of Advanced Thyroid Cancer Market report are Combination therapy, Solo Medication

What are the Type segmentation covered in the Medicine for the Treatment of Advanced Thyroid Cancer Market report?

Ans: The Types covered in the Medicine for the Treatment of Advanced Thyroid Cancer Market report are Cabozantinib, Sorafenib, Vandetanib, Lenvatinib

1 Medicine for the Treatment of Advanced Thyroid Cancer Market Overview
1.1 Product Definition
1.2 Medicine for the Treatment of Advanced Thyroid Cancer by Type
1.2.1 Global Medicine for the Treatment of Advanced Thyroid Cancer Market Value Comparison by Type (2024 VS 2031)
1.2.2 Cabozantinib
1.2.3 Sorafenib
1.2.4 Vandetanib
1.2.5 Lenvatinib
1.3 Medicine for the Treatment of Advanced Thyroid Cancer by Application
1.3.1 Global Medicine for the Treatment of Advanced Thyroid Cancer Market Value by Application (2024 VS 2031)
1.3.2 Combination therapy
1.3.3 Solo Medication
1.4 Global Medicine for the Treatment of Advanced Thyroid Cancer Market Size Estimates and Forecasts
1.4.1 Global Medicine for the Treatment of Advanced Thyroid Cancer Revenue 2020-2031
1.4.2 Global Medicine for the Treatment of Advanced Thyroid Cancer Sales 2020-2031
1.4.3 Global Medicine for the Treatment of Advanced Thyroid Cancer Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Medicine for the Treatment of Advanced Thyroid Cancer Market Competition by Manufacturers
2.1 Global Medicine for the Treatment of Advanced Thyroid Cancer Sales Market Share by Manufacturers (2020-2025)
2.2 Global Medicine for the Treatment of Advanced Thyroid Cancer Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Medicine for the Treatment of Advanced Thyroid Cancer Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Medicine for the Treatment of Advanced Thyroid Cancer, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Medicine for the Treatment of Advanced Thyroid Cancer, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Medicine for the Treatment of Advanced Thyroid Cancer, Product Type & Application
2.7 Global Key Manufacturers of Medicine for the Treatment of Advanced Thyroid Cancer, Date of Enter into This Industry
2.8 Global Medicine for the Treatment of Advanced Thyroid Cancer Market Competitive Situation and Trends
2.8.1 Global Medicine for the Treatment of Advanced Thyroid Cancer Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Medicine for the Treatment of Advanced Thyroid Cancer Players Market Share by Revenue
2.8.3 Global Medicine for the Treatment of Advanced Thyroid Cancer Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Medicine for the Treatment of Advanced Thyroid Cancer Market Scenario by Region
3.1 Global Medicine for the Treatment of Advanced Thyroid Cancer Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Medicine for the Treatment of Advanced Thyroid Cancer Sales by Region: 2020-2031
3.2.1 Global Medicine for the Treatment of Advanced Thyroid Cancer Sales by Region: 2020-2025
3.2.2 Global Medicine for the Treatment of Advanced Thyroid Cancer Sales by Region: 2026-2031
3.3 Global Medicine for the Treatment of Advanced Thyroid Cancer Revenue by Region: 2020-2031
3.3.1 Global Medicine for the Treatment of Advanced Thyroid Cancer Revenue by Region: 2020-2025
3.3.2 Global Medicine for the Treatment of Advanced Thyroid Cancer Revenue by Region: 2026-2031
3.4 North America Medicine for the Treatment of Advanced Thyroid Cancer Market Facts & Figures by Country
3.4.1 North America Medicine for the Treatment of Advanced Thyroid Cancer Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Medicine for the Treatment of Advanced Thyroid Cancer Sales by Country (2020-2031)
3.4.3 North America Medicine for the Treatment of Advanced Thyroid Cancer Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Medicine for the Treatment of Advanced Thyroid Cancer Market Facts & Figures by Country
3.5.1 Europe Medicine for the Treatment of Advanced Thyroid Cancer Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Medicine for the Treatment of Advanced Thyroid Cancer Sales by Country (2020-2031)
3.5.3 Europe Medicine for the Treatment of Advanced Thyroid Cancer Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Medicine for the Treatment of Advanced Thyroid Cancer Market Facts & Figures by Region
3.6.1 Asia Pacific Medicine for the Treatment of Advanced Thyroid Cancer Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Medicine for the Treatment of Advanced Thyroid Cancer Sales by Region (2020-2031)
3.6.3 Asia Pacific Medicine for the Treatment of Advanced Thyroid Cancer Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Medicine for the Treatment of Advanced Thyroid Cancer Market Facts & Figures by Country
3.7.1 Latin America Medicine for the Treatment of Advanced Thyroid Cancer Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Medicine for the Treatment of Advanced Thyroid Cancer Sales by Country (2020-2031)
3.7.3 Latin America Medicine for the Treatment of Advanced Thyroid Cancer Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Medicine for the Treatment of Advanced Thyroid Cancer Market Facts & Figures by Country
3.8.1 Middle East and Africa Medicine for the Treatment of Advanced Thyroid Cancer Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Medicine for the Treatment of Advanced Thyroid Cancer Sales by Country (2020-2031)
3.8.3 Middle East and Africa Medicine for the Treatment of Advanced Thyroid Cancer Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Medicine for the Treatment of Advanced Thyroid Cancer Sales by Type (2020-2031)
4.1.1 Global Medicine for the Treatment of Advanced Thyroid Cancer Sales by Type (2020-2025)
4.1.2 Global Medicine for the Treatment of Advanced Thyroid Cancer Sales by Type (2026-2031)
4.1.3 Global Medicine for the Treatment of Advanced Thyroid Cancer Sales Market Share by Type (2020-2031)
4.2 Global Medicine for the Treatment of Advanced Thyroid Cancer Revenue by Type (2020-2031)
4.2.1 Global Medicine for the Treatment of Advanced Thyroid Cancer Revenue by Type (2020-2025)
4.2.2 Global Medicine for the Treatment of Advanced Thyroid Cancer Revenue by Type (2026-2031)
4.2.3 Global Medicine for the Treatment of Advanced Thyroid Cancer Revenue Market Share by Type (2020-2031)
4.3 Global Medicine for the Treatment of Advanced Thyroid Cancer Price by Type (2020-2031)
5 Segment by Application
5.1 Global Medicine for the Treatment of Advanced Thyroid Cancer Sales by Application (2020-2031)
5.1.1 Global Medicine for the Treatment of Advanced Thyroid Cancer Sales by Application (2020-2025)
5.1.2 Global Medicine for the Treatment of Advanced Thyroid Cancer Sales by Application (2026-2031)
5.1.3 Global Medicine for the Treatment of Advanced Thyroid Cancer Sales Market Share by Application (2020-2031)
5.2 Global Medicine for the Treatment of Advanced Thyroid Cancer Revenue by Application (2020-2031)
5.2.1 Global Medicine for the Treatment of Advanced Thyroid Cancer Revenue by Application (2020-2025)
5.2.2 Global Medicine for the Treatment of Advanced Thyroid Cancer Revenue by Application (2026-2031)
5.2.3 Global Medicine for the Treatment of Advanced Thyroid Cancer Revenue Market Share by Application (2020-2031)
5.3 Global Medicine for the Treatment of Advanced Thyroid Cancer Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Bayer
6.1.1 Bayer Company Information
6.1.2 Bayer Description and Business Overview
6.1.3 Bayer Medicine for the Treatment of Advanced Thyroid Cancer Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Bayer Medicine for the Treatment of Advanced Thyroid Cancer Product Portfolio
6.1.5 Bayer Recent Developments/Updates
6.2 AstraZeneca
6.2.1 AstraZeneca Company Information
6.2.2 AstraZeneca Description and Business Overview
6.2.3 AstraZeneca Medicine for the Treatment of Advanced Thyroid Cancer Sales, Revenue and Gross Margin (2020-2025)
6.2.4 AstraZeneca Medicine for the Treatment of Advanced Thyroid Cancer Product Portfolio
6.2.5 AstraZeneca Recent Developments/Updates
6.3 Sanofi
6.3.1 Sanofi Company Information
6.3.2 Sanofi Description and Business Overview
6.3.3 Sanofi Medicine for the Treatment of Advanced Thyroid Cancer Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Sanofi Medicine for the Treatment of Advanced Thyroid Cancer Product Portfolio
6.3.5 Sanofi Recent Developments/Updates
6.4 Exelixis Inc.
6.4.1 Exelixis Inc. Company Information
6.4.2 Exelixis Inc. Description and Business Overview
6.4.3 Exelixis Inc. Medicine for the Treatment of Advanced Thyroid Cancer Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Exelixis Inc. Medicine for the Treatment of Advanced Thyroid Cancer Product Portfolio
6.4.5 Exelixis Inc. Recent Developments/Updates
6.5 Ipsen Pharma
6.5.1 Ipsen Pharma Company Information
6.5.2 Ipsen Pharma Description and Business Overview
6.5.3 Ipsen Pharma Medicine for the Treatment of Advanced Thyroid Cancer Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Ipsen Pharma Medicine for the Treatment of Advanced Thyroid Cancer Product Portfolio
6.5.5 Ipsen Pharma Recent Developments/Updates
6.6 Eisai Inc
6.6.1 Eisai Inc Company Information
6.6.2 Eisai Inc Description and Business Overview
6.6.3 Eisai Inc Medicine for the Treatment of Advanced Thyroid Cancer Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Eisai Inc Medicine for the Treatment of Advanced Thyroid Cancer Product Portfolio
6.6.5 Eisai Inc Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Medicine for the Treatment of Advanced Thyroid Cancer Industry Chain Analysis
7.2 Medicine for the Treatment of Advanced Thyroid Cancer Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Medicine for the Treatment of Advanced Thyroid Cancer Production Mode & Process Analysis
7.4 Medicine for the Treatment of Advanced Thyroid Cancer Sales and Marketing
7.4.1 Medicine for the Treatment of Advanced Thyroid Cancer Sales Channels
7.4.2 Medicine for the Treatment of Advanced Thyroid Cancer Distributors
7.5 Medicine for the Treatment of Advanced Thyroid Cancer Customer Analysis
8 Medicine for the Treatment of Advanced Thyroid Cancer Market Dynamics
8.1 Medicine for the Treatment of Advanced Thyroid Cancer Industry Trends
8.2 Medicine for the Treatment of Advanced Thyroid Cancer Market Drivers
8.3 Medicine for the Treatment of Advanced Thyroid Cancer Market Challenges
8.4 Medicine for the Treatment of Advanced Thyroid Cancer Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Bayer
Astrazeneca plc
Sanofi
Exelixis Inc
Ipsen Pharma
Eisai Co Ltd
List of Tables
 Table 1. Global Medicine for the Treatment of Advanced Thyroid Cancer Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Medicine for the Treatment of Advanced Thyroid Cancer Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Medicine for the Treatment of Advanced Thyroid Cancer Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Medicine for the Treatment of Advanced Thyroid Cancer Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Medicine for the Treatment of Advanced Thyroid Cancer Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Medicine for the Treatment of Advanced Thyroid Cancer Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Medicine for the Treatment of Advanced Thyroid Cancer Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Medicine for the Treatment of Advanced Thyroid Cancer Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Medicine for the Treatment of Advanced Thyroid Cancer, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Medicine for the Treatment of Advanced Thyroid Cancer, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Medicine for the Treatment of Advanced Thyroid Cancer, Product Type & Application
 Table 12. Global Key Manufacturers of Medicine for the Treatment of Advanced Thyroid Cancer, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Medicine for the Treatment of Advanced Thyroid Cancer by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Medicine for the Treatment of Advanced Thyroid Cancer as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Medicine for the Treatment of Advanced Thyroid Cancer Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Medicine for the Treatment of Advanced Thyroid Cancer Sales by Region (2020-2025) & (K Units)
 Table 18. Global Medicine for the Treatment of Advanced Thyroid Cancer Sales Market Share by Region (2020-2025)
 Table 19. Global Medicine for the Treatment of Advanced Thyroid Cancer Sales by Region (2026-2031) & (K Units)
 Table 20. Global Medicine for the Treatment of Advanced Thyroid Cancer Sales Market Share by Region (2026-2031)
 Table 21. Global Medicine for the Treatment of Advanced Thyroid Cancer Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Medicine for the Treatment of Advanced Thyroid Cancer Revenue Market Share by Region (2020-2025)
 Table 23. Global Medicine for the Treatment of Advanced Thyroid Cancer Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Medicine for the Treatment of Advanced Thyroid Cancer Revenue Market Share by Region (2026-2031)
 Table 25. North America Medicine for the Treatment of Advanced Thyroid Cancer Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Medicine for the Treatment of Advanced Thyroid Cancer Sales by Country (2020-2025) & (K Units)
 Table 27. North America Medicine for the Treatment of Advanced Thyroid Cancer Sales by Country (2026-2031) & (K Units)
 Table 28. North America Medicine for the Treatment of Advanced Thyroid Cancer Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Medicine for the Treatment of Advanced Thyroid Cancer Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Medicine for the Treatment of Advanced Thyroid Cancer Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Medicine for the Treatment of Advanced Thyroid Cancer Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Medicine for the Treatment of Advanced Thyroid Cancer Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Medicine for the Treatment of Advanced Thyroid Cancer Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Medicine for the Treatment of Advanced Thyroid Cancer Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Medicine for the Treatment of Advanced Thyroid Cancer Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Medicine for the Treatment of Advanced Thyroid Cancer Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Medicine for the Treatment of Advanced Thyroid Cancer Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Medicine for the Treatment of Advanced Thyroid Cancer Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Medicine for the Treatment of Advanced Thyroid Cancer Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Medicine for the Treatment of Advanced Thyroid Cancer Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Medicine for the Treatment of Advanced Thyroid Cancer Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Medicine for the Treatment of Advanced Thyroid Cancer Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Medicine for the Treatment of Advanced Thyroid Cancer Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Medicine for the Treatment of Advanced Thyroid Cancer Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Medicine for the Treatment of Advanced Thyroid Cancer Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Medicine for the Treatment of Advanced Thyroid Cancer Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Medicine for the Treatment of Advanced Thyroid Cancer Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Medicine for the Treatment of Advanced Thyroid Cancer Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Medicine for the Treatment of Advanced Thyroid Cancer Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Medicine for the Treatment of Advanced Thyroid Cancer Sales (K Units) by Type (2020-2025)
 Table 51. Global Medicine for the Treatment of Advanced Thyroid Cancer Sales (K Units) by Type (2026-2031)
 Table 52. Global Medicine for the Treatment of Advanced Thyroid Cancer Sales Market Share by Type (2020-2025)
 Table 53. Global Medicine for the Treatment of Advanced Thyroid Cancer Sales Market Share by Type (2026-2031)
 Table 54. Global Medicine for the Treatment of Advanced Thyroid Cancer Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Medicine for the Treatment of Advanced Thyroid Cancer Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Medicine for the Treatment of Advanced Thyroid Cancer Revenue Market Share by Type (2020-2025)
 Table 57. Global Medicine for the Treatment of Advanced Thyroid Cancer Revenue Market Share by Type (2026-2031)
 Table 58. Global Medicine for the Treatment of Advanced Thyroid Cancer Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Medicine for the Treatment of Advanced Thyroid Cancer Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Medicine for the Treatment of Advanced Thyroid Cancer Sales (K Units) by Application (2020-2025)
 Table 61. Global Medicine for the Treatment of Advanced Thyroid Cancer Sales (K Units) by Application (2026-2031)
 Table 62. Global Medicine for the Treatment of Advanced Thyroid Cancer Sales Market Share by Application (2020-2025)
 Table 63. Global Medicine for the Treatment of Advanced Thyroid Cancer Sales Market Share by Application (2026-2031)
 Table 64. Global Medicine for the Treatment of Advanced Thyroid Cancer Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Medicine for the Treatment of Advanced Thyroid Cancer Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Medicine for the Treatment of Advanced Thyroid Cancer Revenue Market Share by Application (2020-2025)
 Table 67. Global Medicine for the Treatment of Advanced Thyroid Cancer Revenue Market Share by Application (2026-2031)
 Table 68. Global Medicine for the Treatment of Advanced Thyroid Cancer Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Medicine for the Treatment of Advanced Thyroid Cancer Price (US$/Unit) by Application (2026-2031)
 Table 70. Bayer Company Information
 Table 71. Bayer Description and Business Overview
 Table 72. Bayer Medicine for the Treatment of Advanced Thyroid Cancer Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Bayer Medicine for the Treatment of Advanced Thyroid Cancer Product
 Table 74. Bayer Recent Developments/Updates
 Table 75. AstraZeneca Company Information
 Table 76. AstraZeneca Description and Business Overview
 Table 77. AstraZeneca Medicine for the Treatment of Advanced Thyroid Cancer Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. AstraZeneca Medicine for the Treatment of Advanced Thyroid Cancer Product
 Table 79. AstraZeneca Recent Developments/Updates
 Table 80. Sanofi Company Information
 Table 81. Sanofi Description and Business Overview
 Table 82. Sanofi Medicine for the Treatment of Advanced Thyroid Cancer Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Sanofi Medicine for the Treatment of Advanced Thyroid Cancer Product
 Table 84. Sanofi Recent Developments/Updates
 Table 85. Exelixis Inc. Company Information
 Table 86. Exelixis Inc. Description and Business Overview
 Table 87. Exelixis Inc. Medicine for the Treatment of Advanced Thyroid Cancer Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Exelixis Inc. Medicine for the Treatment of Advanced Thyroid Cancer Product
 Table 89. Exelixis Inc. Recent Developments/Updates
 Table 90. Ipsen Pharma Company Information
 Table 91. Ipsen Pharma Description and Business Overview
 Table 92. Ipsen Pharma Medicine for the Treatment of Advanced Thyroid Cancer Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Ipsen Pharma Medicine for the Treatment of Advanced Thyroid Cancer Product
 Table 94. Ipsen Pharma Recent Developments/Updates
 Table 95. Eisai Inc Company Information
 Table 96. Eisai Inc Description and Business Overview
 Table 97. Eisai Inc Medicine for the Treatment of Advanced Thyroid Cancer Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Eisai Inc Medicine for the Treatment of Advanced Thyroid Cancer Product
 Table 99. Eisai Inc Recent Developments/Updates
 Table 100. Key Raw Materials Lists
 Table 101. Raw Materials Key Suppliers Lists
 Table 102. Medicine for the Treatment of Advanced Thyroid Cancer Distributors List
 Table 103. Medicine for the Treatment of Advanced Thyroid Cancer Customers List
 Table 104. Medicine for the Treatment of Advanced Thyroid Cancer Market Trends
 Table 105. Medicine for the Treatment of Advanced Thyroid Cancer Market Drivers
 Table 106. Medicine for the Treatment of Advanced Thyroid Cancer Market Challenges
 Table 107. Medicine for the Treatment of Advanced Thyroid Cancer Market Restraints
 Table 108. Research Programs/Design for This Report
 Table 109. Key Data Information from Secondary Sources
 Table 110. Key Data Information from Primary Sources
 Table 111. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Medicine for the Treatment of Advanced Thyroid Cancer
 Figure 2. Global Medicine for the Treatment of Advanced Thyroid Cancer Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Medicine for the Treatment of Advanced Thyroid Cancer Market Share by Type: 2024 & 2031
 Figure 4. Cabozantinib Product Picture
 Figure 5. Sorafenib Product Picture
 Figure 6. Vandetanib Product Picture
 Figure 7. Lenvatinib Product Picture
 Figure 8. Global Medicine for the Treatment of Advanced Thyroid Cancer Market Value by Application (2020-2031) & (US$ Million)
 Figure 9. Global Medicine for the Treatment of Advanced Thyroid Cancer Market Share by Application: 2024 & 2031
 Figure 10. Combination therapy
 Figure 11. Solo Medication
 Figure 12. Global Medicine for the Treatment of Advanced Thyroid Cancer Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 13. Global Medicine for the Treatment of Advanced Thyroid Cancer Market Size (2020-2031) & (US$ Million)
 Figure 14. Global Medicine for the Treatment of Advanced Thyroid Cancer Sales (2020-2031) & (K Units)
 Figure 15. Global Medicine for the Treatment of Advanced Thyroid Cancer Average Price (US$/Unit) & (2020-2031)
 Figure 16. Medicine for the Treatment of Advanced Thyroid Cancer Report Years Considered
 Figure 17. Medicine for the Treatment of Advanced Thyroid Cancer Sales Share by Manufacturers in 2024
 Figure 18. Global Medicine for the Treatment of Advanced Thyroid Cancer Revenue Share by Manufacturers in 2024
 Figure 19. Global 5 and 10 Largest Medicine for the Treatment of Advanced Thyroid Cancer Players: Market Share by Revenue in Medicine for the Treatment of Advanced Thyroid Cancer in 2024
 Figure 20. Medicine for the Treatment of Advanced Thyroid Cancer Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 21. Global Medicine for the Treatment of Advanced Thyroid Cancer Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 22. North America Medicine for the Treatment of Advanced Thyroid Cancer Sales Market Share by Country (2020-2031)
 Figure 23. North America Medicine for the Treatment of Advanced Thyroid Cancer Revenue Market Share by Country (2020-2031)
 Figure 24. U.S. Medicine for the Treatment of Advanced Thyroid Cancer Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Canada Medicine for the Treatment of Advanced Thyroid Cancer Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 26. Europe Medicine for the Treatment of Advanced Thyroid Cancer Sales Market Share by Country (2020-2031)
 Figure 27. Europe Medicine for the Treatment of Advanced Thyroid Cancer Revenue Market Share by Country (2020-2031)
 Figure 28. Germany Medicine for the Treatment of Advanced Thyroid Cancer Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. France Medicine for the Treatment of Advanced Thyroid Cancer Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. U.K. Medicine for the Treatment of Advanced Thyroid Cancer Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Italy Medicine for the Treatment of Advanced Thyroid Cancer Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Russia Medicine for the Treatment of Advanced Thyroid Cancer Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Asia Pacific Medicine for the Treatment of Advanced Thyroid Cancer Sales Market Share by Region (2020-2031)
 Figure 34. Asia Pacific Medicine for the Treatment of Advanced Thyroid Cancer Revenue Market Share by Region (2020-2031)
 Figure 35. China Medicine for the Treatment of Advanced Thyroid Cancer Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. Japan Medicine for the Treatment of Advanced Thyroid Cancer Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. South Korea Medicine for the Treatment of Advanced Thyroid Cancer Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. India Medicine for the Treatment of Advanced Thyroid Cancer Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Australia Medicine for the Treatment of Advanced Thyroid Cancer Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Taiwan Medicine for the Treatment of Advanced Thyroid Cancer Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Indonesia Medicine for the Treatment of Advanced Thyroid Cancer Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Thailand Medicine for the Treatment of Advanced Thyroid Cancer Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Malaysia Medicine for the Treatment of Advanced Thyroid Cancer Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Philippines Medicine for the Treatment of Advanced Thyroid Cancer Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Latin America Medicine for the Treatment of Advanced Thyroid Cancer Sales Market Share by Country (2020-2031)
 Figure 46. Latin America Medicine for the Treatment of Advanced Thyroid Cancer Revenue Market Share by Country (2020-2031)
 Figure 47. Mexico Medicine for the Treatment of Advanced Thyroid Cancer Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Brazil Medicine for the Treatment of Advanced Thyroid Cancer Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Argentina Medicine for the Treatment of Advanced Thyroid Cancer Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Middle East and Africa Medicine for the Treatment of Advanced Thyroid Cancer Sales Market Share by Country (2020-2031)
 Figure 51. Middle East and Africa Medicine for the Treatment of Advanced Thyroid Cancer Revenue Market Share by Country (2020-2031)
 Figure 52. Turkey Medicine for the Treatment of Advanced Thyroid Cancer Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Saudi Arabia Medicine for the Treatment of Advanced Thyroid Cancer Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. UAE Medicine for the Treatment of Advanced Thyroid Cancer Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 55. Global Sales Market Share of Medicine for the Treatment of Advanced Thyroid Cancer by Type (2020-2031)
 Figure 56. Global Revenue Market Share of Medicine for the Treatment of Advanced Thyroid Cancer by Type (2020-2031)
 Figure 57. Global Medicine for the Treatment of Advanced Thyroid Cancer Price (US$/Unit) by Type (2020-2031)
 Figure 58. Global Sales Market Share of Medicine for the Treatment of Advanced Thyroid Cancer by Application (2020-2031)
 Figure 59. Global Revenue Market Share of Medicine for the Treatment of Advanced Thyroid Cancer by Application (2020-2031)
 Figure 60. Global Medicine for the Treatment of Advanced Thyroid Cancer Price (US$/Unit) by Application (2020-2031)
 Figure 61. Medicine for the Treatment of Advanced Thyroid Cancer Value Chain
 Figure 62. Channels of Distribution (Direct Vs Distribution)
 Figure 63. Bottom-up and Top-down Approaches for This Report
 Figure 64. Data Triangulation
 Figure 65. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Bioinformatics Barcelona

SIMILAR REPORTS

Global Lenvatinib Market Research Report 2024
Global Vandetanib Tablets Market Research Report 2024
Differentiated Thyroid Cancer Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Drugs for Differentiated Thyroid Cancer Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Differentiated Thyroid Cancer Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Lenvatinib Drugs Market Research Report 2024
Differentiated Thyroid Cancer Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Anaplastic Thyroid Cancer Therapeutics Market Insights Forecast to 2030
Global Anaplastic Thyroid Cancer Treatment Market Insights Forecast to 2030
Global Follicular Thyroid Cancer Drug Market Research Report 2025
Papillary Thyroid Carcinoma Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Cabozantinib Drugs Market Research Report 2024
Papillary Thyroid Cancer Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Cabozantinib Drug Market Research Report 2024
Thyroid Cancer Diagnostic Market
Global Radioactive Therapeutic Drugs Market Research Report 2024
Global Hepatocellular Carcinoma Targeted Drug Market Research Report 2025
Global Endocrine Therapy Medication Market Research Report 2024
Global Hepatoma Cell Targeted Drug Market Research Report 2025
Global Thyroid Cancer Molecular Diagnostics Market Research Report 2024

RELATED REPORTS

Global Hormonal Therapy for Cancer Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-5L19798
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Cancer Insurance Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-28I6901
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Induced Myeloid Leukemia Cell Differentiation Protein Mcl 1 Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-22R9736
Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Global Drugs for Differentiated Thyroid Cancer Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-29A2598
Tue Sep 09 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions